Skip to content

Compare the value of endoscopic ultrasonography with different frequencies in the diagnosis of early upper gastrointestinal cancer and submucosal tumors

Compare the value of endoscopic ultrasonography with different frequencies in the diagnosis of early upper gastrointestinal cancer and submucosal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101197
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-04-22
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early cancer and submucosal tumor of upper digestive tract

Interventions

Gold Standard:Pathological diagnosis
Index test:12MHz and 20 MHz ultrasound probes

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily sign the informed consent form; 2. Aged between 18 and 85; 3. The 8th edition of the TNM staging of esophageal cancer and gastric cancer jointly released by the American Cancer Federation (AJCC) and the International Union Against Cancer (UICC) in 2017 is standardized for patients diagnosed with early cancer of the upper gastrointestinal tract and patients diagnosed with submucosal masses by the "ACG Clinical Guidelines: Diagnosis and Management of Gastrointestinal Subepithelial Lesions (2023 Edition)". 4. According to the judgment of the treating doctor, endoscopic dissection or surgical treatment is required.

Exclusion criteria

Exclusion criteria: 1. Upper gastrointestinal T2-T4 disease; 2. Submucosal mass> 2cm; 3. Multiple lesions, 75%-100% periphery; 4. Previous EUS, CT, or MRI showing lymph node involvement or distant metastases; 5. Have received radiotherapy or chemotherapy; 6. Severe organ insufficiency, pregnancy, lactation or planning to become pregnant and/or other uncontrollable diseases; 7. Judged by the investigator to be unsuitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Accuracy;Sensitivity;Specificity;

Secondary

MeasureTime frame
Positive predicative value;Negative predictive value;

Countries

China

Contacts

Public ContactWang Xinke

Nanfang Hospital, Southern Medical University

55900975@qq.com+86 156 2643 2307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026